# US 2019/0314006 A1 · Device and method for preparing and administering one-component fibrin sealant

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314006 A1
- Document ID: US20190314006A1
- Status: Published application
- Kind: A1
- Application number: 16/412,487
- Filed: 2019-05-15
- Published: 2019-10-17
- Earliest claimed: 2014-03-27
- Assignees: Ethicon, Inc.; Omrix Biopharmaceuticals Ltd.
- Applicants: Ethicon, Inc.; Omrix Biopharmaceuticals Ltd.
- Inventors: Ashley DeAnglis; Yair Pilpel; Yuri Zherdev; Sivan Doron; Lior Erez
- Web page: https://patentgrep.com/patent/US20190314006A1

## CPC

- A61B 17/00491: {Surgical glue applicators}
- A61K 38/36: Blood coagulation or fibrinolysis factors
- A61K 38/363: {Fibrinogen}
- A61K 38/4833: {Thrombin (3.4.21.5)}
- A61L 24/106: {Fibrin; Fibrinogen}
- A61M 3/005: {comprising means for injection of two or more media, e.g. by mixing}
- A61M 2202/045: Fibrin
- C12Y 304/21005: Thrombin (3.4.21.5)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- C12Y: ENZYMES

## Abstract

Provided herein are systems for preparing and delivering fibrin sealant to a surface and methods of use thereof. In one embodiment, the system comprises: a. a quantity of a liquid mixture disposed within a container, the mixture comprising: I. fibrin or II. fibrinogen and Factor II; and b. a resin bed disposed within a vessel, the vessel capable of being in fluid communication with the container, wherein when in fluid communication, passage of the mixture through the vessel results in modification of the concentration of small molecules inhibitor(s) and/or inducer(s) within the mixture, favoring fibrin clot formation.

## Claims

### Claim 1

A device for preparing and delivering fibrin sealant to a surface, the device comprising:
a. a syringe comprising a barrel and a plunger, wherein the barrel contains a quantity of a cell-free liquid mixture comprising:
fibrin
and
at least one small molecule inhibitor of fibrin clot formation;
b. a resin bed comprising a size-exclusion chromatographic resin, the resin bed being disposed within a vessel such that when an interior of the syringe barrel is in fluid communication with the resin bed, expulsion of the mixture from the barrel by the plunger forces the mixture to pass through the resin bed within the vessel resulting in reduction in a concentration of the inhibitor(s) within the mixture, wherein following the passage through the vessel, a fibrin clot is formed with a clotting time (TCLOT) of at most 1 hour at an ambient temperature selected from the group consisting of 21° C., 22° C., 23° C., 24° C., and 25° C.

### Claim 2 (depends on 1)

The device according to claim 1, wherein before passing the liquid mixture through the resin bed, the liquid mixture within the syringe barrel is stable for at least two weeks.

### Claim 3 (depends on 1)

The device according to claim 1, wherein the resin bed is a packed bed.

### Claim 4 (depends on 1)

The device according to claim 1, further comprising an application tip capable of being in fluid communication with a distal end of the vessel so that, when in fluid communication, the fibrin sealant is delivered through the application tip to the surface.

### Claim 5 (depends on 1)

The device according to claim 1, wherein the barrel and the vessel are mechanically coupled to each other so that respective interiors thereof separated by a removable barrier and/or at least one of (i) a septum, (ii) one way filter, (iii) a valve, and (iv) stopcock.

### Claim at position 6

-7. (canceled)

### Claim 8 (depends on 1)

The device according to claim 1, wherein a ratio between:
i. a concentration of 30+ kDa proteins in the mixture before passage through the resin bed; and
ii. a concentration of 30+ kDa proteins in the fibrin sealant after passage through the resin bed,
is about 1.

### Claim 9 (depends on 1)

The device according to claim 1, configured so that fibrin sealant is prepared from the liquid mixture after a retention time of at most 1 minute, or at most 45 seconds, or at most 30 seconds, or at most 15 seconds, or at most 10 seconds, or at most 5 seconds, or at most 3 seconds, or at most 1 second, optionally configured so that expulsion of the liquid mixture from the barrel forces the mixture to flow through the resin bed in a manner that is substantially uniform over a cross-section of the resin bed.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

The device according to claim 1, wherein the device comprises at least one mesh, the mesh configured to distribute the flow over the resin bed and/or retain the resin beads within the bed.

### Claim 12 (depends on 1)

The device according to claim 1, wherein the resin bed resides within the vessel such that the liquid mixture passes through a grid and subsequently through a filter-paper en route to the resin bed, the grid configured to provide mechanical support during the application of pressure as well as spread the flow over the filter paper, and the filter-paper configured to distribute the flow over the resin bed and retain the resin beads within the bed.

### Claim 13 (depends on 1)

The device according to claim 1, wherein a height of the resin bed is at most 10 cm, or at most 7.5 cm, or at most 5 cm, or at most 2.5 cm, or at most 2 cm, or at most 1.5 cm, or at most 1 cm, optionally wherein a height of the resin bed is at least 0.5 cm.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The device according to claim 1, wherein a width of the resin bed is at most 5 cm, or at most 2.5 cm, or at most 1.3 cm.

### Claim 16 (depends on 1)

The device according to claim 1, wherein a ratio between a height of the resin bed and a characteristic width thereof is at most 2.5, or at most 2, or at most 1.5, or at most 1 or at most 0.75 and/or at least 0.5.

### Claim 17 (depends on 1)

The device according to claim 1, wherein the quantity of the liquid mixture within the syringe barrel has a volume of at least 0.5 ml, or at least 1 ml and/or at most 15 ml, or at most 10 ml, or at most 5 ml.

### Claim 18 (depends on 1)

The device according to claim 1, configured so that a force of at most 30 Newtons applied to the plunger over a period of time of at most 60 seconds is sufficient to force a majority of the liquid mixture stored within the barrel through the resin bed at a retention time of at most 60 seconds.

### Claim 19

(canceled)

### Claim 20 (depends on 1)

The device according to claim 1, wherein a volume ratio between (i) a volume of the liquid mixture within the syringe barrel and (ii) a volume of the resin bed is in the range of about 0.1 to about 10, optionally in the range of about 0.2 to about 5, or optionally in the range of about 0.3 to about 1.

### Claim at position 20

-22. (canceled)

### Claim 23 (depends on 1)

The device according to claim 1, wherein the liquid mixture comprises fibrinogen and Factor II.

### Claim 24 (depends on 23)

The device according to claim 23, wherein the inhibitor(s) is a serine protease active site inhibitor and/or a calcium chelator.

### Claim at position 23

-26. (canceled)

### Claim 27 (depends on 1)

The device according to claim 1, wherein the liquid mixture comprises fibrin in monomeric, dimeric and/or oligomeric form.

### Claim 28 (depends on 27)

The device according to claim 27, wherein the liquid mixture is sustained in a neutral pH, and wherein the inhibitor is a GPRP peptide or other reversible fibrin polymerization blocking agent.

### Claim 29 (depends on 27)

The device according to claim 27, wherein the liquid mixture is sustained in an acidic pH, and wherein the inhibitor is a hydronium ion (H3O+).

### Claim at position 27

-36. (canceled)
